Dr. Christine Lu-Emerson
Claim this profileMaine Medical Center- Scarborough Campus
Studies Glioblastoma
Studies Brain Tumor
8 reported clinical trials
18 drugs studied
Area of expertise
1Glioblastoma
MET negative
IDH negative
MET positive
2Brain Tumor
IDH positive
1p/19q co-deletion positive
1p/19q positive
Affiliated Hospitals
Clinical Trials Christine Lu-Emerson is currently running
Lenalidomide + Nivolumab
for Lymphoma
This trial tests a combination of drugs to treat a rare brain cancer. The treatment aims to starve the tumor, boost the immune system, and stop cancer cells from growing. It targets patients with primary CNS lymphoma who may not respond well to standard treatments.
Recruiting1 award Phase 119 criteria
Relatlimab + Nivolumab
for Recurrent Glioblastoma
This phase II trial compares the safety, side effects and effectiveness of anti-lag-3 (relatlimab) and anti-PD-1 blockade (nivolumab) to standard of care lomustine for the treatment of patients with glioblastoma that has come back after a period of improvement (recurrent). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's deoxyribonucleic acid and may kill tumor cells. Giving relatlimab and nivolumab may be safe, tolerable, and/or effective compared to standard of care lomustine in treating patients with recurrent glioblastoma.
Recruiting1 award Phase 215 criteria
More about Christine Lu-Emerson
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christine Lu-Emerson has experience with
- Nivolumab
- Temozolomide
- Optune®
- Proton Beam Radiation Therapy
- IMRT (Intensity-Modulated Radiation Therapy)
- Ipilimumab
Breakdown of trials Christine Lu-Emerson has run
Glioblastoma
Brain Tumor
Protoplasmic Astrocytoma
Oligodendroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Lu-Emerson specialize in?
Christine Lu-Emerson focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MET negative patients, or patients who are IDH negative.
Is Christine Lu-Emerson currently recruiting for clinical trials?
Yes, Christine Lu-Emerson is currently recruiting for 2 clinical trials in Scarborough Maine. If you're interested in participating, you should apply.
Are there any treatments that Christine Lu-Emerson has studied deeply?
Yes, Christine Lu-Emerson has studied treatments such as Nivolumab, Temozolomide, Optune®.
What is the best way to schedule an appointment with Christine Lu-Emerson?
Apply for one of the trials that Christine Lu-Emerson is conducting.
What is the office address of Christine Lu-Emerson?
The office of Christine Lu-Emerson is located at: Maine Medical Center- Scarborough Campus, Scarborough, Maine 04074 United States. This is the address for their practice at the Maine Medical Center- Scarborough Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.